Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

A new boson with a mass of 125 GeV observed with the CMS experiment at the Large Hadron Collider.

CMS Collaboration.

Science. 2012 Dec 21;338(6114):1569-75. doi: 10.1126/science.1230816. Erratum in: Science. 2013 Mar 15;339(6125):1275.

2.

Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis.

EVOLVE Trial Investigators, Chertow GM, Block GA, Correa-Rotter R, Dr├╝eke TB, Floege J, Goodman WG, Herzog CA, Kubo Y, London GM, Mahaffey KW, Mix TC, Moe SM, Trotman ML, Wheeler DC, Parfrey PS.

N Engl J Med. 2012 Dec 27;367(26):2482-94. doi: 10.1056/NEJMoa1205624. Epub 2012 Nov 3.

3.

Bias towards dementia: are hip fracture trials excluding too many patients? A systematic review.

Hebert-Davies J, Laflamme GY, Rouleau D; HEALTH and FAITH investigators.

Injury. 2012 Dec;43(12):1978-84. doi: 10.1016/j.injury.2012.08.061. Epub 2012 Sep 19. Review.

PMID:
22999009
4.

Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial.

Easton JD, Lopes RD, Bahit MC, Wojdyla DM, Granger CB, Wallentin L, Alings M, Goto S, Lewis BS, Rosenqvist M, Hanna M, Mohan P, Alexander JH, Diener HC; ARISTOTLE Committees and Investigators.

Lancet Neurol. 2012 Jun;11(6):503-11. doi: 10.1016/S1474-4422(12)70092-3. Epub 2012 May 8. Erratum in: Lancet Neurol. 2012 Dec;11(12):1021.

PMID:
22572202
5.

Central coordination as an alternative for local coordination in a multicenter randomized controlled trial: the FAITH trial experience.

Zielinski SM, Viveiros H, Heetveld MJ, Swiontkowski MF, Bhandari M, Patka P, Van Lieshout EM; FAITH trial investigators.

Trials. 2012 Jan 8;13:5. doi: 10.1186/1745-6215-13-5.

Supplemental Content

Loading ...
Support Center